Menu Search
Equities

Althea Group Holdings Ltd

AGH:ASX

Althea Group Holdings Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.03
  • Today's Change0.002 / 7.14%
  • Shares traded2.41m
  • 1 Year change-14.29%
  • Beta1.8269
Data delayed at least 20 minutes, as of Sep 20 2024 07:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Althea Group Holdings Ltd had net income fall 133.57% from a loss of 13.73m to a larger loss of 32.06m despite revenues that grew 20.87% from 25.13m to 30.37m over the same period.
Gross margin60.70%
Net profit margin-105.54%
Operating margin-101.35%
Return on assets-89.06%
Return on equity-213.12%
Return on investment-167.97%
More ▼

Cash flow in AUDView more

In 2024, cash reserves at Althea Group Holdings Ltd fell by 3.54m. However, Cash Flow from Investing totalled 2.29m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 4.40m for operations while cash used for financing totalled 1.44m.
Cash flow per share-0.0794
Price/Cash flow per share--
Book value per share0.0008
Tangible book value per share-0.0005
More ▼

Balance sheet in AUDView more

Althea Group Holdings Ltd has a Debt to Total Capital ratio of 94.66%, a higher figure than the previous year's 2.64%.
Current ratio0.6442
Quick ratio0.4086
Total debt/total equity17.73
Total debt/total capital0.9466
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.